BG104673A - Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis - Google Patents

Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis

Info

Publication number
BG104673A
BG104673A BG104673A BG10467300A BG104673A BG 104673 A BG104673 A BG 104673A BG 104673 A BG104673 A BG 104673A BG 10467300 A BG10467300 A BG 10467300A BG 104673 A BG104673 A BG 104673A
Authority
BG
Bulgaria
Prior art keywords
leishmaniasis
treatment
oral administration
solid pharmaceutical
compositions containing
Prior art date
Application number
BG104673A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG64968B1 (bg
Inventor
Juergen Engel
Werner Sarlikiotis
Thomas Klenner
Peter Hilgard
Dieter Sauerbier
Eckhard Milsmann
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Priority to BG104673A priority Critical patent/BG64968B1/bg
Publication of BG104673A publication Critical patent/BG104673A/xx
Publication of BG64968B1 publication Critical patent/BG64968B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG104673A 2000-08-07 2000-08-07 Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis BG64968B1 (bg)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG104673A BG64968B1 (bg) 2000-08-07 2000-08-07 Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG104673A BG64968B1 (bg) 2000-08-07 2000-08-07 Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis

Publications (2)

Publication Number Publication Date
BG104673A true BG104673A (en) 2001-05-31
BG64968B1 BG64968B1 (bg) 2006-11-30

Family

ID=37496913

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104673A BG64968B1 (bg) 2000-08-07 2000-08-07 Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis

Country Status (1)

Country Link
BG (1) BG64968B1 (xx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis

Also Published As

Publication number Publication date
BG64968B1 (bg) 2006-11-30

Similar Documents

Publication Publication Date Title
IL136196A0 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
PL334566A1 (en) Treatment of sclerosis multiplex by oral and inhalatory administration of a copolymer-1
MY129422A (en) Medicinal compounds
EP1049459A4 (en) ORAL LIQUID COMPOSITIONS
BR9914251A (pt) Formulações orais de liberação sustentada
BG105564A (en) Galantamine-containing composition with controlled release
BG104727A (en) Pharmaceutical composition of topiramate
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
YU21999A (sh) Farmaceutske smese i postupak za njihovo dobijanje
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA01004547A (es) Administracion oral de analogos de adenosina.
FI20011703A7 (fi) Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä
BG105292A (en) Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
IL139320A0 (en) Pharmaceutical compositions containing human parathyroid hormone
MY119090A (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them
RS44204A (xx) Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
NZ320355A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
SI1525188T1 (sl) Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo
RS44304A (xx) Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
BR0014440A (pt) Formulações de liberação controlada oral